Games Global makes US IPO filing public-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Games Global makes US IPO filing public

Apr 16, 2024 2:39 PM

April 16 (Reuters) - UK-based online gaming company

Games Global on Tuesday made public its paperwork for an initial

public offering in the United States.

Previous page： Meta's Instagram down for thousands, Downdetector shows Next page： CERAWEEK-Exxon ahead of schedule on doubling LNG portfolio, exec says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Meta's Instagram down for thousands, Downdetector shows

Mar 21, 2024

March 21 (Reuters) - Meta Platforms's ( META ) Instagram was down for thousands of users on Thursday, according to outage tracking website Downdetector.com. ...

CERAWEEK-Exxon ahead of schedule on doubling LNG portfolio, exec says

Mar 21, 2024

HOUSTON, March 21 (Reuters) - Exxon Mobil ( XOM ) is ahead of schedule with its plan to double the size of its liquefied natural gas (LNG) portfolio to 40 million tons per annum (mtpa) by 2030 and will focus on selling its own gas rather than trading that of third parties, the company's LNG chief said on Thursday. Exxon...

Boeing chair to meet key airline customers without planemaker's CEO, sources say

Mar 21, 2024

WASHINGTON, March 21 (Reuters) - Major airline chiefs plan to hold discussions with Boeing ( BA ) board chair Larry Kellner in meetings that will not include CEO David Calhoun after raising concerns over an Alaska Airlines mid-air emergency and ongoing production issues, sources said. A group of U.S. airline CEOs sought meetings with Boeing ( BA ) directors to...

US FDA approves Italfarmaco's drug for Duchenne muscle-wasting disorder

Mar 21, 2024

By Mariam Sunny and Sruthi Narasimha Chari March 21 (Reuters) - The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD), an inherited muscle-wasting disorder, the health regulator said on Thursday. The oral drug, to be sold under the brand name Duvyzat, is the first nonsteroidal drug approved to treat patients with all genetic...